Exacerbation of Graves ophthalmopathy with interferon-alpha therapy.
Thyroid dysfunction, particularly hypothyroidism, following interferon-alpha therapy is not uncommon. To our knowledge, this is the first case report of exacerbation of Graves ophthalmopathy during treatment with interferon-alpha for chronic hepatitis C virus.
DeMartelaere
Sheri L
SL
Texas Oculoplastic Consultants, Austin, Texas 78705, USA.
Green
M Kelly
MK
Shore
John W
JW
D000998:Antiviral Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005094:Exophthalmos / Q000139:chemically induced / Q000000981:diagnostic imaging; D005260:Female; D049970:Graves Ophthalmopathy / Q000139:chemically induced* / Q000000981:diagnostic imaging; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects*; D008875:Middle Aged; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed
D000998:Antiviral Agents; D007370:Interferon Type I; D011994:Recombinant Proteins; D012254:Ribavirin